Minda Industries issues commercial papers worth Rs 50 crore; climbs over 3 per cent Minda Industries issues commercial papers worth Rs 50 crore; climbs over 3 per cent Ganesh V / Saturday, March 20, 2021 / Article rating: 3.0 Minda Industries announced on Friday that it has issued commercial papers of Rs 50 crore with an allotment date of March 18, 2021, which is due to mature on June 16, 2021. The company has issued these commercial papers to bring down the finance cost.
Aarti Drugs zooms nearly 10 per cent after board approves buyback worth Rs 60 crore Aarti Drugs zooms nearly 10 per cent after board approves buyback worth Rs 60 crore Ganesh V / Saturday, March 20, 2021 / Article rating: 3.5 The board of Aarti Drugs proposed to buy back up to 6 lakh equity shares of the company at Rs 1,000 per share. The aggregate consideration of the buyback shall not exceed Rs 60 crore.
Best performing AMCs in February 2021 for equity investing Best performing AMCs in February 2021 for equity investing Henil Shah / Saturday, March 20, 2021 / Article rating: 3.5 Though HDFC AMC tops when it comes to AUM, Nippon India AMC tops in terms of performance. Read onto find out the best performing AMCs in February 2021.
Weekly Economic Update Weekly Economic Update Srinivasa Sharan / Friday, March 19, 2021 / Article rating: 3.5 A sumary of the most important economic news for the week including the US central bank's decision on interest rates
Sensex, Nifty close in green; Intellect Design jumps 14 per cent, Aarti Drugs gains 10 per cent, Future Group stocks plunge Sensex, Nifty close in green; Intellect Design jumps 14 per cent, Aarti Drugs gains 10 per cent, Future Group stocks plunge Geyatee Deshpande / Friday, March 19, 2021 / Article rating: 5.0 Bulls made a comeback at D-Street as domestic benchmark indices snapped their 5-day losing streak to end the week in the positive territory. On Friday, Sensex surged by 641.72 points or by 1.30 per cent, to close at 49,858.24 levels while Nifty jumped by 186.15 points or 1.28 per cent to settle at 14,744 levels.
RDIF and Stelis Biopharma collaborate to supply 200 million doses of Sputnik V vaccine RDIF and Stelis Biopharma collaborate to supply 200 million doses of Sputnik V vaccine Abhinav Lahoti / Friday, March 19, 2021 / Article rating: 5.0 Russian Direct Investment Fund (RDIF) and the biopharmaceutical division of Strides Pharma Ltd namely, Stelis Biopharma Pvt Ltd have partnered together to produce & supply a minimum of 200 million doses of Russian COVID-19 vaccine, Sputnik V.
Ten stocks close to their 52-week high Ten stocks close to their 52-week high Ganesh Pawar / Friday, March 19, 2021 / Article rating: 5.0 The market opened in red on March 19, 2021.
Stelis Biopharma winds up series B & C fundraise amounting to US$ 195 million Stelis Biopharma winds up series B & C fundraise amounting to US$ 195 million Shruti Dahiwal / Friday, March 19, 2021 / Article rating: 5.0 Stelis Biopharma, a pharmaceutical division of Strides Pharma Science Ltd, announced today that it has successfully completed its series B & C fundraise which amounted to US$ 195 million. This fundraise reinforces the growth potential of the company and enables the company to pursue growth initiatives and scale-up its business further.
Dilip Buildcon slumps over 5 per cent despite securing orders worth Rs 2,241 crore Dilip Buildcon slumps over 5 per cent despite securing orders worth Rs 2,241 crore Abhinav Lahoti / Friday, March 19, 2021 / Article rating: 4.8 Dilip Buildcon Ltd has received a letter of acceptance (LoA) from National Highways Authority of India (NHAI) for the construction of two highways worth Rs 2,241 crore.
Five stocks with buying interest Five stocks with buying interest Ganesh Pawar / Friday, March 19, 2021 / Article rating: 4.0 The market opened in red on March 19, 2021, overall volumes in futures & options currently stand at 9,84,90,136 contracts with a turnover of Rs. 92,56,631.31 crore.